Protein behind Rheumatoid Arthritis Found
Researchers at Imperial College London have discovered a protein that triggers rheumatoid arthritis.
Risk from Common Painkillers
A study says that over-the-counter painkillers, used for treating inflammation, can increase the risk of heart attacks and strokes.
Tysabri for the Treatment of Multiple Sclerosis
Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.
NEWS REVIEW | PRODUCT NEWS
[This article was published in the September 2010 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Transasia brings UF 1000i, automated urine particle analyser
Older version of allergy drugs may be dangerous for people
Global Allergy and Asthma European Network (GA2LEN) and the European Academy of Allergy and Clinical Immunology (EAACI) have come up with a finding that that the older generation of HI-antihistamines that are used as allergy medicines may be dangerous to people’s health.
Cellworks in collaboration with Orchid on drug discovery
Cellworks Research India, the Bangalore-based research and development (R&D) wing of Cellworks Group Inc (California-headquartered company), has assisted Chennai-based Orchid Chemicals and Pharmaceuticals by providing system biology technology in carrying out ongoing New Chemical Entity (NCE) research programme.
First health institute in Nagaland
[This article was published in the December 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
Cellworks Group Inc. forays into India through R & D centre in Bangalore
Cellworks Group Inc, a California based company, has set up its R&D centre in Bangalore, India. Cellworks Research India Limited (CRIL), the R&D centre of Cellworks, would develop and provide technology based solutions that hasten drug discovery research and development.
